Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

Naganuma, Makoto; Nakamura, Naohiro; Kunisaki, Reiko; Matsuoka, Katsuyoshi; Yamamoto, Shojiro; Kawamoto, Ami; Saito, Daisuke; Kobayashi, Taku; Nanki, Kosaku; Narimatsu, Kazuyuki; Shiga, Hisashi; Esaki, Motohiro; Yoshioka, Shinichiro; Kato, Shingo; Saruta, Masayuki; Tanaka, Shinji; Yasutomi, Eriko; Yokoyama, Kaoru; Moriya, Kei; Tsuzuki, Yoshikazu; Ooi, Makoto; Fujiya, Mikihiro; Nakazawa, Atsushi; Takagi, Tomohisa; Omori, Teppei; Tahara, Toshiyuki; Hisamatsu, Tadakazu; ,; Kunisaki, Reiko; Yamamoto, Shojiro; Ogawa, Souichiro; Tamura, Hotaka; Uchida, Keisuke; Fukui, Toshiro; Fukata, Norimasa; Nakamura, Naohiro; Sano, Yasuki; Honzawa, Yusuke; Matsuoka, Katsuyoshi; Kawamoto, Ami; Nagahori, Masakazu; Okamoto, Ryuichi; Saito, Daisuke; Miura, Miki; Hisamatsu, Tadakazu; Nanki, Kosaku; Yoshimatsu, Yusuke; Narimatsu, Kazuyuki; Hokari, Ryota; Shiga, Hisashi; Kakuta, Yoichi; Fukuda, Tomohiro; Hojyo, Aya; Sagami, Shintaro; Kobayashi, Taku; Hibi, Toshufumi; Sakata, Yasuhisa; Esaki, Motohiro; Yoshioka, Shinichiro; Tsuruta, Kozo; Morita, Masaru; Mitsuyama, Keiichi; Kato, Shingo; Shibuya, Naoki; Miyazaki, Ryosuke; Saruta, Masayuki; Hayashi, Ryohei; Tanaka, Shinji; Yasutomi, Eriko; Hiraoka, Sakiko; Yokoyama, Kaoru; Kobayashi, Kiyonori; Kajiwara, Mariko; Takagi, Tomohisa; Moriya, Kei; Tsuzuki, Yoshikazu; Imaeda, Hiroyuki; Tokunaga, Eri; Ooi, Mitsuru; Ueno, Nobuhiro; Fujiya, Mikihiro; Tahara, Toshiyuki; Yokoyama, Ayumu; Nakazawa, Atsushi; Murasugi, Shun; Kuriyama, Tomoko; Omori, Teppei; Takeuchi, Ken; Hashimoto, Shinichi; Hirayama, Daisuke; Kazama, Tomoe; Nakase, Hiroshi; Miyazaki, Takako; Nakamura, Shiro; Oka, Akihiko; Kawashima, Kousaku; Ishihara, Shunji; Yanai, Shunichi; Matsumoto, Takayuki; Sato, Toshiyuki; Yokoyama, Yoko; Watanabe, Kenji; Yamamoto, Yasunori; Hiasa, Yoichi; Bamba, Hideki; Ando, Akira; Ohta, Yuki; Kanayama, Kengo; Kato, Jun; Omiya, Naoki; Nanjyo, Sohachi

doi:10.1007/s00535-024-02079-x

J Gastroenterol

2024

DOI: 10.1007/s00535-024-02079-x

|View full text |Cite

Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

Makoto Naganuma,

Naohiro Nakamura,

Reiko Kunisaki

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite1

Independent2

Authors

Journals

Cited by 3 publications

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”

Naganuma

2024

J Gastroenterol

Self Cite

View full text Add to dashboard Cite

with clinical remission? With the exception of overeating and extreme fat intake, it is desirable to minimize dietary restrictions during patients with remission.We recently demonstrated in multicenter prospective cohort study that advanced therapy as well as corticosteroids was effective as the first-line treatment in hospitalized patients [3,4], although the influence of dietary restriction was not investigated in our study. While recent guidelines indicated that corticosteroid is the first-line treatment for hospitalized patients with severe disease, we would like to emphasize that use of advanced therapy may be acceptable for patients with acute severe UC. Although there are many advanced therapies, these treatments should be selected according to the clinical background and severity of disease [3,4]. The effects of dietary therapy on hospitalized patients should be investigated by accumulating a large number of cases.

show abstract

Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”

Naganuma

2024

J Gastroenterol

Self Cite

View full text Add to dashboard Cite

show abstract

Severe ulcerative colitis: diagnostic criteria and therapy

Chiba

2024

J Gastroenterol

View full text Add to dashboard Cite

Reply to “Severe ulcerative colitis: diagnostic criteria and therapy”

Naganuma

2024

J Gastroenterol

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

Cited by 3 publications

References 26 publications

Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”

Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”

Severe ulcerative colitis: diagnostic criteria and therapy

Reply to “Severe ulcerative colitis: diagnostic criteria and therapy”

Contact Info

Product

Resources

About